c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene.
about
Ginkgo biloba extract individually inhibits JNK activation and induces c-Jun degradation in human chondrocytes: potential therapeutics for osteoarthritisDifferentially expressed epigenome modifiers, including aurora kinases A and B, in immune cells in rheumatoid arthritis in humans and mouse models.Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer.Induction of angiogenic chemokine CCL2 by human herpesvirus 8 chemokine receptor.p38α (MAPK14) critically regulates the immunological response and the production of specific cytokines and chemokines in astrocytes.Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal eliminationHigher gene expression variability in the more aggressive subtype of chronic lymphocytic leukemia.Epigenetics in the pathogenesis of rheumatoid arthritis.c-Jun N-terminal kinase phosphorylates DCP1a to control formation of P bodiesAuto-activation of c-JUN gene by amino acid deprivation of hepatocellular carcinoma cells reveals a novel c-JUN-mediated signaling pathway.Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages.Activation of tachykinin, neurokinin 3 receptors affects chromatin structure and gene expression by means of histone acetylationThe coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB.Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter.The zinc finger transcription factor ZXDC activates CCL2 gene expression by opposing BCL6-mediated repression.Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium.Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury.Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinasec-Jun, at the crossroad of the signaling network.Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes.A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma.Dynamic changes in chromatin conformation at the TNF transcription start site in T helper lymphocyte subsets.Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch-Nyhan disease: BODIPY-forskolin as pharmacological tool.NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells.CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity.Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cellsIdentification of a minimal cis-element and cognate trans-factor(s) required for induction of Rac2 gene expression during K562 cell differentiation.Quantum dots trigger immunomodulation of the NFκB pathway in human skin cellsc-Jun-N-terminal phosphorylation regulates DNMT1 expression and genome wide methylation in gliomasHistone deacetylase inhibitors block nuclear factor-κB-dependent transcription by interfering with RNA polymerase II recruitment.Large-scale network models of IL-1 and IL-6 signalling and their hepatocellular specification.Targeting Heat Shock Protein 70 to Ameliorate c-Jun Expression and Improve Demyelinating Neuropathy.Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis.RNAi-Based Identification of Gene-Specific Nuclear Cofactor Networks Regulating Interleukin-1 Target Genes.CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer.Interstitial lung disease induced by gefitinib and Toll-like receptor ligands is mediated by Fra-1
P2860
Q28536785-C454A2AD-20FE-40C5-94B6-3416B5C371BCQ33915660-55FAE3DA-8515-4571-B141-6294916C2AABQ34101036-D21B5B99-7FC1-42C4-9291-FB710D0C26EFQ34392493-9D260EDA-F9E9-4FBA-8905-48DB2C2B30E5Q34508261-6DC8CA3E-C2D9-4646-8D8C-847DD6B1837DQ34684156-C53E9E2C-F900-43AB-A476-8BFB5DB6819AQ34959023-68BE018E-6804-4690-B7B2-0454D59D2935Q35021249-EF1DB33A-63A3-4F98-8C18-81FC4D4AA0AAQ35102634-717A359D-808C-4001-955A-299425B88BC4Q35178122-FFABBDAF-E689-4509-8C69-ED31FF8279F8Q35379187-79CA3D4C-1336-4704-8CDA-2B7B11A74554Q36342694-14F49846-611C-482F-83DB-C13DDC9E47A8Q36442907-51F8EFD7-7C57-45AC-8DB9-10A631D0E163Q36668758-8A7C7C22-3FFA-46E8-96A8-3A7957894940Q36862292-E5BD088F-5582-4F69-A94A-56160EF762C3Q37198551-6E7373A3-F97F-4924-B930-C4D0E3C210A2Q37414113-CF22D87F-8943-497C-9605-80F8009947C4Q37455704-9AC016DF-F6D3-4C07-9B29-9C32E1055DDDQ37794385-155E2601-315E-4B92-A8F6-56EEA0E9232DQ37969687-D357F061-C8F6-45FF-99B0-9D5DB9A59B34Q38292180-FAFD4984-9FF2-4D07-A2BF-5A25E21C808AQ39023415-F015CD30-4017-4739-A6C7-CC2E3547469DQ39099558-9FA9387C-808C-4BDB-A0E7-9961C1430F57Q39340075-4B83E9B0-F541-4541-BF8A-A36A295853C8Q39354809-73DC0011-47B6-46DD-BF51-AE42CB6BAC5CQ39606322-C4839F86-F16B-4EBE-8A3C-CC73ABBF9F81Q39782144-0E5D25AC-F680-4691-8B5D-860A445CFFE3Q39811482-5ADBA689-966D-4AE2-B7BD-E1D54A75A8BBQ41436495-393EBE07-C85E-48D3-9BCA-2DCF40629149Q42044261-A9BED359-CFB1-4547-A405-2697D397F951Q42316245-06510631-B540-4920-9C72-1FB60F8D3DA1Q45820993-6289F5EB-BB81-4E6F-9231-A84B5A7B5BFEQ46684257-C4183C64-EC2A-4532-A6F1-8F8777821E56Q47421684-A25BF0D6-6A93-4C2E-85C9-0D0A2B7CEDC9Q53704947-0BE6E9D6-6998-4828-AA26-A0A279450F67Q55011825-B178D9DE-0F19-4AE3-BD22-54418A816A25Q55513244-11B053B6-8945-44ED-B632-111FDDBC8A25Q56762982-F2A408B6-E75F-473E-8178-1BB054E9CF56
P2860
c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
c-Jun controls histone modific ...... ion to activate the ccl2 gene.
@en
type
label
c-Jun controls histone modific ...... ion to activate the ccl2 gene.
@en
prefLabel
c-Jun controls histone modific ...... ion to activate the ccl2 gene.
@en
P2093
P2860
P356
P1476
c-Jun controls histone modific ...... ion to activate the ccl2 gene.
@en
P2093
Anneke Doerrie
Axel Weber
Elke Hoffmann
Heike Schneider
Juliane von der Ohe
Klaus Resch
Latifa Bakiri
Sabine Wolter
P2860
P304
P356
10.1128/MCB.00535-07
P407
P577
2008-04-28T00:00:00Z